NCT07174011Phase 4Completed
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata: A Randomized Controlled Trial.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 4
- Sponsor
- Cairo University
- Participants (registry)
- 50
- Start
- January 2025
- Primary completion
- May 2025
- Study completion
- August 2025
- Last registry update
- September 2025
- Countries
- Egypt
Conditions studied: Alopecia, Alopecia Areata
Interventions: Roflumilast, intralesional steroid
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.